Psychedelic therapy Psychedelic therapy Psychedelic therapy refers to therapeutic practices involving psychedelic drugs, oftentimes utilizing serotonergic psychedelics such as LSD, psilocybin, DMT, MDMA, mescaline, and 2C-B. Psychedelic therapy, in contrast to conventional psychiatric medication taken by the patient regularly or as-needed, patients generally remain in an extended psychotherapy session during the acute psychedelic activity with additional sessions both before and after in order to help integrate experiences with the drug. Psychedelic therapy, in the broadest possible sense of the term, may have originated from prehistoric knowledge of hallucinogenic plants. They grow naturally in certain cacti, seeds, bark and roots of various plants.
Merrilactone A disease and Parkinson's disease. Merrilactone A occurs naturally in "Illicium merrillianum", a plant indigenous to southern China and Myanmar. The genus "Illicium" belongs to the family "Illiciaceae" and is an evergreen shrub or tree. Approximately 40 species are disjunctively distributed in eastern North America, Mexico, the West Indies, and eastern Asia. The highest concentration of species is in northern Myanmar and southern China, where nearly 35 species have been described. The fruits of the "Illicium" species are distinctive star-shaped follicles that have a characteristic refreshing flavour. The fruits of "Illicium merrillianum" also have an aromatic odor, bland taste and cause